Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Formula of oral Chinese medicine used for treating virus myocarditis

A technology for viral myocarditis and traditional Chinese medicine, which is used in pharmaceutical formulations, antiviral agents, medical preparations containing active ingredients, etc.

Inactive Publication Date: 2006-08-30
吴文发
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Most of the existing medicines for the treatment of viral myocarditis are western medicines, and the treatment methods are generally supportive treatment or broad-spectrum antiviral drugs, and rest and increase nutrition, and no specific treatment error has been formed yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0008] The traditional Chinese medicine formula of the present invention is in the form of a prescription, mainly composed of kudzu root, American ginseng, raw gypsum, comfrey and borneol. And then according to the different course of disease of acute myocarditis and chronic myocarditis, select different specific formula for use.

[0009] The formula for the treatment of initial stage (acute myocarditis) further contains Pueraria puerariae 2.4g; American ginseng 0.8g; raw gypsum 1.2g; comfrey 0.2g; mint leaves 0.3g; fried malt 0.3g; borneol 0.04g. Suitable for

[0010] The formula for treating myocarditis in the chronic phase further contains Pueraria puerariae 2.0g; Raw yam 1.0g; American ginseng 1.0g; Chanyi 0.3g; Comfrey 0.3g; Symptoms are not obvious.

[0011] When taking, the above medicines are first ground into powder respectively, and the medicines of different flavors cannot be mixed during the grinding process. And the grinding is limited to manual grinding and ca...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An orally taken Chinese medicine for treating viral myocarditis is prepared from 5-7 Chinese-medicinal materials including American ginseng, gypsum, arnebia root, borneol, etc. Two prescriptions for different stages are disclosed.

Description

technical field [0001] The invention relates to an oral Chinese medicine formula, in particular to an oral Chinese medicine formula for treating viral myocarditis. Background technique [0002] Viral myocarditis is a common disease with increasing incidence and a serious threat to people's health. Most of the existing medicines for the treatment of viral myocarditis are western medicines, and the treatment methods are generally supportive treatment or broad-spectrum antiviral medicines, and rest and nutrition increase, and specific treatment errors have not yet been formed. There are few medicines for the treatment of myocarditis by traditional Chinese medicine, and the formula of traditional Chinese medicine is seldom seen in the treatment cases of myocarditis. Contents of the invention [0003] The object of the present invention is to provide a traditional Chinese medicine oral formula for treating viral myocarditis, which has the effect of specifically treating myocar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/488A61K31/045A61K33/06A61P31/12A61P9/00
Inventor 吴文发
Owner 吴文发
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products